Crosstalk via the NF-κB signaling system

Cytokine and Growth Factor Reviews

Volumn 19, Issue 3-4, 2008, Pages 187-197

  Basak, Soumen ^a   Hoffmann, Alexander ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Mathematical modeling; NF B, system emergent properties; Organogenesis

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; CHEMOKINE; CYTOKINE; DIMER; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN BETA RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P50; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; BINDING AFFINITY; CELL FUNCTION; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNE RESPONSE; INFLAMMATION; LYMPH NODE; MATHEMATICAL MODEL; MOLECULAR BIOLOGY; NONHUMAN; ORGANOGENESIS; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; GROWTH AND DEVELOPMENT; IMMUNITY; INFLAMMATION; LYMPHOID TISSUE; MICE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 44749088134     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2008.04.005     Document Type: Article

References (63)

1. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 210 (2006) 171-186
2. Zabel U., and Baeuerle P.A. Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell 61 (1990) 255-265
3. Li Z., and Nabel G.J. A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription. Mol Cell Biol 17 (1997) 6184-6190
4. Whiteside S.T., Epinat J.C., Rice N.R., and Israel A. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J 16 (1997) 1413-1426
5. Huxford T., Huang D.B., Malek S., and Ghosh G. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell 95 (1998) 759-770
6. Baeuerle P.A., and Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 53 (1988) 211-217
7. Baeuerle P.A., and Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242 (1988) 540-546
8. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl. (2002) S81-S96
9. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25 (2006) 6685-6705
10. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18 (2000) 621-663
11. DiDonato J.A., Mercurio F., and Karin M. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol 15 (1995) 1302-1311
12. Neumann M., and Naumann M. Beyond IkappaBs: alternative regulation of NF-kappaB activity. FASEB J 21 (2007) 2642-2654
13. Hoffmann A., Levchenko A., Scott M.L., and Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298 (2002) 1241-1245
14. Kearns J.D., Basak S., Werner S.L., Huang C.S., and Hoffmann A. IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. J Cell Biol 173 (2006) 659-664
15. Covert M.W., Leung T.H., Gaston J.E., and Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309 (2005) 1854-1857
16. Werner S.L., Barken D., and Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309 (2005) 1857-1861
17. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., and Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376 (1995) 167-170
18. Alcamo E., Mizgerd J.P., Horwitz B.H., Bronson R., Beg A.A., Scott M., et al. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol 167 (2001) 1592-1600
19. Alcamo E., Hacohen N., Schulte L.C., Rennert P.D., Hynes R.O., and Baltimore D. Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs. J Exp Med 195 (2002) 233-244
20. Sha W.C., Liou H.C., Tuomanen E.I., and Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80 (1995) 321-330
21. Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 9 (1995) 1965-1977
22. Boothby M.R., Mora A.L., Scherer D.C., Brockman J.A., and Ballard D.W. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med 185 (1997) 1897-1907
23. Zheng Y., Vig M., Lyons J., Van Parijs L., and Beg A.A. Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J Exp Med 197 (2003) 861-874
24. Ouaaz F., Arron J., Zheng Y., Choi Y., and Beg A.A. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 16 (2002) 257-270
25. Hoffmann A., Leung T.H., and Baltimore D. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J 22 (2003) 5530-5539
26. Wang J., Wang X., Hussain S., Zheng Y., Sanjabi S., Ouaaz F., et al. Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cell. J Immunol 178 (2007) 6777-6788
27. Schreiber J., Jenner R.G., Murray H.L., Gerber G.K., Gifford D.K., and Young R.A. Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci U S A 103 (2006) 5899-5904
28. Martone R., Euskirchen G., Bertone P., Hartman S., Royce T.E., Luscombe N.M., et al. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci U S A 100 (2003) 12247-12252
29. Mebius R. Otrganogenesis of lymphoid tissues. Nat Rev Immunol 3 (2003) 292-303
30. Lo J.C., Basak S., James E.S., Quiambo R.S., Kinsella M.C., Alegre M.L., et al. Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues. Blood 107 (2006) 1048-1055
31. Futterer A., Mink K., Luz A., Kosco-Vilbois M.H., and Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9 (1998) 59-70
32. Rennert P.D., James D., Mackay F., Browning J.L., and Hochman P.S. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 9 (1998) 71-79
33. Fu Y.X., and Chaplin D.D. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 17 (1999) 399-433
34. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17 (2002) 525-535
35. Basak S., Kim H., Kearns J.D., Tergaonkar V., O'Dea E., Werner S.L., et al. A fourth IkappaB protein within the NF-kappaB signaling module. Cell 128 (2007) 369-381
36. Xiao G., Fong A., and Sun S.C. Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J Biol Chem 279 (2004) 30099-30105
37. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293 (2001) 1495-1499
38. Pomerantz J.L., and Baltimore D. Two pathways to NF-kappaB. Mol Cell 10 (2002) 693-695
39. Yin L., Wu L., Wesche H., Arthur C.D., White J.M., Goeddel D.V., et al. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291 (2001) 2162-2165
40. Ramakrishnan P., Wang W., and Wallach D. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity 21 (2004) 477-489
41. de Wit H., Dokter W.H., Koopmans S.B., Lummen C., van der Leij M., Smit J.W., et al. Regulation of p100 (NFKB2) expression in human monocytes in response to inflammatory mediators and lymphokines. Leukemia 12 (1998) 363-370
42. Neumann B., Luz A., Pfeffer K., and Holzmann B. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med 184 (1996) 259-264
43. Katakai T., Hara T., Sugai M., Gonda H., and Shimizu A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med 200 (2004) 783-795
44. Wang Y.G., Kim K.D., Wang J., Yu P., and Fu Y.X. Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion. J Immunol 175 (2005) 6997-7002
45. Walsh M.C., Kim N., Kadono Y., Rho J., Lee S.Y., Lorenzo J., et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24 (2006) 33-63
46. Yamashita T., Yao Z., Li F., Zhang Q., Badell I.R., Schwarz E.M., et al. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem 282 (2007) 18245-18253
47. Zhang Y.H., Heulsmann A., Tondravi M.M., Mukherjee A., and Abu-Amer Y. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 276 (2001) 563-568
48. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
49. Dejardin E., Bonizzi G., Bellahcene A., Castronovo V., Merville M.P., and Bours V. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11 (1995) 1835-1841
50. Rebholz B., Haase I., Eckelt B., Paxian S., Flaig M.J., Ghoreschi K., et al. Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. Immunity 27 (2007) 296-307
51. Krappmann D., Emmerich F., Kordes U., Scharschmidt E., Dorken B., and Scheidereit C. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 18 (1999) 943-953
52. Chiu A., Xu W., He B., Dillon S.R., Gross J.A., Sievers E., et al. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood 109 (2007) 729-739
53. Annunziata C.M., Davis R.E., Demchenko Y., Bellamy W., Gabrea A., Zhan F., et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12 (2007) 115-130
54. Keats J.J., Fonseca R., Chesi M., Schop R., Baker A., Chng W.J., et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12 (2007) 131-144
55. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
56. Mordmuller B., Krappmann D., Esen M., Wegener E., and Scheidereit C. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism. EMBO Rep 4 (2003) 82-87
57. Xiao G., Harhaj E.W., and Sun S.C. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7 (2001) 401-409
58. Muller J.R., and Siebenlist U. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J Biol Chem 278 (2003) 12006-12012
59. Basak S., Shih V.F., and Hoffmann A. Generation and activation of multiple dimeric transcription factors within the NF-κB signaling system. Mol Cell Biol 28 (2008) 3139-3150
60. Weih D.S., Yilmaz Z.B., and Weih F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol 167 (2001) 1909-1919
61. Yilmaz Z.B., Weih D.S., Sivakumar V., and Weih F. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J 22 (2003) 121-130
62. Schneider K., Potter K.G., and Ware C.F. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 202 (2004) 49-66
63. Bonizzi G., Bebien M., Otero D.C., Johnson-Vroom K.E., Cao Y., Vu D., et al. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB, p52 dimers. EMBO J 23 (2004) 4202-4210